Fairvalue-Calculator Fairvalue-Calculator
EN DE

Akums Drugs and Pharmaceuticals Limited (AKUMS) Fair Value & Analysis

Healthcare · IN · Market cap ₹93.0B

Price₹609.35
Fair Value₹333.36
Upside-45.3%
Quality96/100
Evidence: High Range ₹250.02 – ₹416.70

Fair value as of: Jun 29, 2026

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Akums Drugs and Pharmaceuticals Limited (AKUMS) currently trades at ₹609.35, while our model-based Fair Value estimate is ₹333.36 — implying the stock looks roughly 45.3% overvalued today. We read business quality at 96/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form-fill-seal products, topical preparations, eye drops, dry powder injections, and gummies for therapeutic areas, such as antiinfectives, pain management, gastroenterology, orthopaedics, cardio-diabetic care, critical care, respiratory, and gynaecology. In addition, the company operates as pharmaceutical contract development and manufacturing company. Akums Drugs and Pharmaceuticals Limited was incorporated in 2004 and is based in Delhi, India.

Open the full interactive analysis →

Similar stocks

Jiangsu Hengrui Pharmaceuticals Co (600276) -43% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -24% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -81% Swedish Orphan Biovitrum AB (SOBI) -1%

Frequently asked questions

Is Akums Drugs and Pharmaceuticals Limited (AKUMS) undervalued?
As of Jun 29, 2026, our model estimates a fair value of ₹333.36 versus a price of ₹609.35 — about −45% (overvalued). Model-based estimate, not financial advice.
What is the fair value of AKUMS?
Our 21-model fair value for Akums Drugs and Pharmaceuticals Limited is ₹333.36 (as of Jun 29, 2026), built from audited fundamentals. The current price is ₹609.35.
What is the quality score of AKUMS?
Akums Drugs and Pharmaceuticals Limited has a Quality Score of 96/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.